Chapter 49: Osteoporosis, Menopause & Testosterone Use Flashcards

1
Q

T Score Results

A

Normal >=1
Osteopenia (low bone mass) -1 to -2.4
Osteoporosis <= -2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Medical Diseases/Conditions that Increase Osteoporosis Risk

A
Anorexia
Diabetes
GI Diseases (IBD, Celiac, Gastric Bypass, malabsoprtion syndrome)
Hyperthyroidism
Hydogonadism in men
Menopause
RA (autoimmune diseases)
Epilepsy
HIV/AIDS
Parkinson disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lifestyle Factors that Increase Osteoporosis Risk

A
Smoking
Excessive Alcohol (>=3 drink/day)
Low Ca intake
Low Vit D intake
Physical Inactivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Medications that Increase Osteoporosis Risk

A
Anticonvulsants
Aromatase Inhibitors
Depo-medroxyprogesterone
GnRH agonists
Lithium
PPIs
Steroids (>=5mg/day of prednisone)
Thyroid Hormones
Heparins
Loops, SSRIs TZD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Calcium Recommended Daily Intake

A

1,000 to 1,200 elemental Ca

Ca Carbonate is 40% elemental
Ca Citrate is 21% elemental

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vitamin D Deficiency

A

Vit D deficiency <30ng/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Vitamin D Deficiency Tx

A

5,000 - 7,000 iu qd
or
50,000iu qw

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bisphosphonates CI

A

Hypocalcemia

Inability to stand or sit upright for at least 30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bisphosphonates Warnings

A
Osteonecrosis of the Jaw
Atypical Femur fractures 
Esophagitis, esophageal ulcers, erorsion
Hypocalcemia
Renal Impairment (do not use of CrCl <35 alendronate or >30 ibandronate/risedronate)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bisphosphonates SE

A
Dyspepsia
Dysphagia
Heartburn
N/V
Hypocalcemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alendronate Dosing

A

10mg/day or 70mg/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risedronate

A

(actonel/atelvia)

5mg po qd
35mg po qweek
150mg q month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ibandronate

A

(Boniva)

150mg po q month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Injectable Bisphosphonates CI

A

Hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Injectable Bisphosphonates Warnings

A

Same as Po

Renal impairment (monitor SCr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Injectable Bisphosphonates Notes

A

Preferred if esophagitis is present (due to risk of esophageal cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ibandronate Injections

A

3mg q3months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Zoledronic Acid

A

(Reclast)

5mg Q year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Bisphosphonates MOA

A

Work by increasing bone density by inhibiting osteoclast activity and bone resorption.
Reduce vertebral and hip fracture risk (except ibandronate only vertebral)
1st line for prevention of osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Raloxifene MOA

A

estrogen agonist/antagonist (SERM) that decreases bone resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Raloxifene Boxed Warnings

A

Increased risk of VTE

Increased risk of death due to stroke

22
Q

Raloxifene CI

A

Hx or current VTE

Pregnancy

23
Q

Raloxifene SE

A

Hot flashes
Peripheral edema
Arthralgia
Leg Cramps

24
Q

Duavee Indication

A

Conjugated estrogens/bazedoxifene

Osteoporosis prevention on postmenopausal women WITH a uterus

25
Q

Duavee Boxed Warnings

A
Endometrial Cancer (due to unopposed estrogen)
Increased risk of DVT
26
Q

Duavee CI

A

Breast Cancer
Pregnancy
Uterine Bleeding
VTE

27
Q

Calcitonin MOA

A

Inhibits bone resorption by osteoclasts

28
Q

Calcitonin Dosing (nasal)

A

1 spray in one nostril qd (alternate nostril daily)

29
Q

Calcitonin Warnings

A

Hypocalcemia
Increased risk of malignancy
Hypersensitivity reaction to salmon derived products

30
Q

Teriparatide and abaloparatide MOA

A

Analogs of human parathyroid hormones, which stimulates osteoblast activity and increases bone formation.

Used to treat osteoporosis when there is a very high risk of fracture

Cumulative lifetime tx duration is 2 years of less

31
Q

Parathyroid Hormone Boxed Warnings

A

Osteosarcoma

32
Q

Parathyroid Hormone Warnings

A

Hypercalcemia

33
Q

Parathyroid Hormone SE

A

Arthralgias
Leg Cramps
Nausea
Orthostasis/Dizziness

34
Q

RANKL Inhibitors

A

Receptor Activator of Nuclear Factor Kappa-B Ligand

MAb thant bind to rankl and blocks its interaction with RANK (a receptor on osteoclasts) to prevent osteoclast formation;

This leads to decreased bone resorption and increase bone mass

35
Q

Denosumab Dosing

A

Prolia

60mg sc q6 months

36
Q

Prolia CI

A

Hypocalcemia

Pregnancy

37
Q

Prolia Warnings

A

ONJ
Femur Fractures
Hypocalcemia

38
Q

Prolia SE

A
Hypertension 
Fatigue
Edema
Dyspnea
Headache
N/V/D
Decreased PO4
39
Q

Estrace

A

17 beta estradiol

Vaginal Cream

40
Q

Estring

A

17 beta estradiol

Vaginal ring

41
Q

Vagifem

A

17 beta estradiol

Vaginal tablet

42
Q

Premarin

A

Conjugated equine estrogens

Vaginal cream

43
Q

Systemic Hormone Therapies Boxed Warnings

A

Endometrial cancer (if estrogen used without progestin in women with uterus)
Dementia (>=65 years)
Increased risk of VTE and stroke
Breast Cancer

44
Q

Systemic Hormone Therapies CI

A

Estrogen containing products and breast cancer
Undiagnosed uterine bleeding
Active VTE
Pregnancy

45
Q

Systemic Hormone Therapies Warnings

A

Increased risk of breast cancer

46
Q

Estradiol Patches

A

Alora and Vivelle dot are biw

Climara qw

47
Q

Natural Products for Menopause

A
Black cohosh
Evening Primrose
Red Clover
Soy
Flaxseed
48
Q

Brisdelle

A

Paroxetine
SSRI for moderate to severe vasomotor symptoms
Do not use with warfarin (increased bleeding risk)
Do not use with tamoxifen (decreased tamoxifen efficacy)

49
Q

Ospemifene

A

Osphena

Oral estrogen agonist/antagonist indicated for dyspareunia (painful intercourse) and moderate to severe vaginal dryness

50
Q

Testosterone Boxed Warnings

A

Secondary exposure in children can result in early virilization

51
Q

Testosterone SE

A
Increased appetite 
Acne
Edema
hepatotoxicity
reduced sperm count